This company has been marked as potentially delisted and may not be actively trading. D8 (DEH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DEH vs. MLSS, APT, LGMK, SYRE, ATAI, CRON, PRAX, INMD, UPB, and IRMDShould you be buying D8 stock or one of its competitors? The main competitors of D8 include Milestone Scientific (MLSS), Alpha Pro Tech (APT), LogicMark (LGMK), Spyre Therapeutics (SYRE), atai Life Sciences (ATAI), Cronos Group (CRON), Praxis Precision Medicines (PRAX), InMode (INMD), Upstream Bio (UPB), and iRadimed (IRMD). D8 vs. Its Competitors Milestone Scientific Alpha Pro Tech LogicMark Spyre Therapeutics atai Life Sciences Cronos Group Praxis Precision Medicines InMode Upstream Bio iRadimed Milestone Scientific (NYSE:MLSS) and D8 (NYSE:DEH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, media sentiment, profitability, analyst recommendations, institutional ownership and valuation. Does the media prefer MLSS or DEH? In the previous week, Milestone Scientific had 1 more articles in the media than D8. MarketBeat recorded 1 mentions for Milestone Scientific and 0 mentions for D8. D8's average media sentiment score of -0.73 beat Milestone Scientific's score of -1.00 indicating that D8 is being referred to more favorably in the news media. Company Overall Sentiment Milestone Scientific Negative D8 Negative Which has stronger earnings and valuation, MLSS or DEH? Milestone Scientific has higher revenue and earnings than D8. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMilestone Scientific$9.08M5.34-$6.93M-$0.09-6.86D8N/AN/A-$9.46MN/AN/A Is MLSS or DEH more profitable? D8 has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. D8's return on equity of 0.00% beat Milestone Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Milestone Scientific-52.01% -60.26% -40.23% D8 N/A N/A N/A Do institutionals & insiders hold more shares of MLSS or DEH? 5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 65.4% of D8 shares are owned by institutional investors. 24.8% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts prefer MLSS or DEH? Milestone Scientific presently has a consensus price target of $1.25, suggesting a potential upside of 102.56%. Given Milestone Scientific's stronger consensus rating and higher probable upside, equities analysts plainly believe Milestone Scientific is more favorable than D8.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00D8 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryMilestone Scientific beats D8 on 7 of the 12 factors compared between the two stocks. Get D8 News Delivered to You Automatically Sign up to receive the latest news and ratings for DEH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DEH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DEH vs. The Competition Export to ExcelMetricD8Surgical Appliances & Supplies IndustryMedical SectorNYSE ExchangeMarket Cap$245.38M$27.14M$5.79B$21.33BDividend YieldN/AN/A6.70%3.48%P/E RatioN/A13.2276.2329.64Price / SalesN/A2.14553.7050.24Price / CashN/A12.8025.7018.12Price / Book47.422.1812.254.58Net Income-$9.46M-$5.31M$3.29B$999.86M D8 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DEHD8N/A$5.69-0.4%N/A-1.4%$245.38MN/A0.003Gap UpMLSSMilestone Scientific1.8935 of 5 stars$0.64+6.9%$1.25+95.3%-40.1%$50.28M$9.08M-9.1430Negative NewsAPTAlpha Pro Tech1.9809 of 5 stars$4.80+0.4%N/A-15.0%$50.27M$58.56M12.97120Short Interest ↓LGMKLogicMark0.7373 of 5 stars$0.00-8.6%N/A-99.9%$1.84M$9.88M0.0020Gap DownSYRESpyre Therapeutics2.2407 of 5 stars$16.81+1.1%$53.40+217.7%-39.2%$1.00BN/A-4.9473ATAIatai Life Sciences3.3883 of 5 stars$4.52-1.5%$11.25+148.9%+284.0%$981.67M$310K-6.5580CRONCronos Group1.537 of 5 stars$2.53+1.2%N/A+16.8%$957.60M$130.28M50.60450PRAXPraxis Precision Medicines2.6524 of 5 stars$46.55+3.6%$85.88+84.5%-13.3%$945.81M$7.77M-3.79110Trending NewsAnalyst RevisionINMDInMode3.7084 of 5 stars$14.51+0.7%$18.04+24.3%-4.5%$944.34M$394.82M5.87480Positive NewsUPBUpstream Bio2.2267 of 5 stars$20.00-1.3%$56.50+182.5%N/A$923.47M$2.37M0.0038News CoveragePositive NewsHigh Trading VolumeIRMDiRadimed4.725 of 5 stars$70.60-1.4%$72.00+2.0%+60.4%$921.44M$73.24M43.58110 Related Companies and Tools Related Companies MLSS Competitors APT Competitors LGMK Competitors SYRE Competitors ATAI Competitors CRON Competitors PRAX Competitors INMD Competitors UPB Competitors IRMD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:DEH) was last updated on 9/8/2025 by MarketBeat.com Staff From Our PartnersThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding D8 Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share D8 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
